Evaluation of the novel liver micronucleus assay using formalin-fixed tissues
Abstract Background The repeated-dose liver micronucleus (RDLMN) assay is an effective and important in vivo test for detecting genotoxic compounds, particularly for those that require metabolic activation to show genotoxicity. In a collaborative study by the Collaborative Study Group for the Micron...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Genes and Environment |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41021-019-0128-5 |
id |
doaj-c18356cee9e44b748aa005238a282ea6 |
---|---|
record_format |
Article |
spelling |
doaj-c18356cee9e44b748aa005238a282ea62020-11-25T02:04:33ZengBMCGenes and Environment1880-70622019-05-014111810.1186/s41021-019-0128-5Evaluation of the novel liver micronucleus assay using formalin-fixed tissuesShuichi Hamada0Miyuki Shigano1Satoru Kawakami2Maya Ueda3Hajime Sui4Katsuya Yamada5Soichiro Hagio6Ayaka Momonami7Akihisa Maeda8Yukari Terashima9Wakako Ohyama10Takeshi Morita11Makoto Hayashi12Safety Assessment Department, Nonclinical Research Center, Drug Development Service Segment, LSI Medience CorporationSafety Assessment Department, Nonclinical Research Center, Drug Development Service Segment, LSI Medience CorporationAsahi Kasei Pharma CorporationBioSafety Research Center Inc.Food and Drug Safety CenterMitsubishi Tanabe Pharma CorporationNissan Chemical CorporationSuntory MONOZUKURI Expert Ltd.Toray Industries Inc.Kissei Pharmaceutical Co., Ltd.Yakult Honsha Co., Ltd.National Institute of Health Sciencesmakoto international consultingAbstract Background The repeated-dose liver micronucleus (RDLMN) assay is an effective and important in vivo test for detecting genotoxic compounds, particularly for those that require metabolic activation to show genotoxicity. In a collaborative study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/The Japanese Environmental Mutagen Society (JEMS) – Mammalian Mutagenicity Study Group (MMS), micronucleus induction of 22 chemicals with the RDLMN assay employing the collagenase digestion method was examined and reported on. Recently, we have developed a method which enables retrospective evaluation of micronucleus induction in formalin-fixed liver tissues (the formalin-fixed method) obtained in general toxicity studies completed in the past. Using this method, we were able to easily evaluate clastogenic potential of chemicals from the formalin-fixed tissues obtained in the general toxicity studies. In this study, to evaluate the usefulness of the formalin-fixed method, we have conducted a liver micronucleus assay using the formalin-fixed liver samples obtained from the above collaborative study (18 of 22 test chemicals) and carried out a comparison with the results obtained by the collagenase digestion method. Results Comparison of the collagenase digestion and formalin-fixed methods was conducted using the results of the micronucleus assays with a total of 18 test chemicals which included 12 genotoxic hepatocarcinogens (Group A), 4 genotoxic carcinogens but not liver targeted (Group B), and 2 nongenotoxic hepatocarcinogens (Group C). The formalin-fixed method obtained the similar results as the collagenase digestion method in 10 out of the 12 chemicals of Group A, and all chemicals of Group B and Group C. Although the results were statistically contradictive due to different levels of concurrent negative control, the 2 other chemicals of Group A showed comparable responses between the two methods. Conclusion The present study shows that the formalin-fixed method is capable of detecting liver carcinogens with sensitivity equal to or higher than that of the collagenase digestion method. We recommend use of the formalin-fixed method because of its capability of enabling retrospective evaluation of micronucleus induction in the formalin-fixed liver tissues obtained in general toxicity studies completed in the past.http://link.springer.com/article/10.1186/s41021-019-0128-5Micronucleus assayLiverFormalin-fixed tissueCollagenaseHepatocyte |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shuichi Hamada Miyuki Shigano Satoru Kawakami Maya Ueda Hajime Sui Katsuya Yamada Soichiro Hagio Ayaka Momonami Akihisa Maeda Yukari Terashima Wakako Ohyama Takeshi Morita Makoto Hayashi |
spellingShingle |
Shuichi Hamada Miyuki Shigano Satoru Kawakami Maya Ueda Hajime Sui Katsuya Yamada Soichiro Hagio Ayaka Momonami Akihisa Maeda Yukari Terashima Wakako Ohyama Takeshi Morita Makoto Hayashi Evaluation of the novel liver micronucleus assay using formalin-fixed tissues Genes and Environment Micronucleus assay Liver Formalin-fixed tissue Collagenase Hepatocyte |
author_facet |
Shuichi Hamada Miyuki Shigano Satoru Kawakami Maya Ueda Hajime Sui Katsuya Yamada Soichiro Hagio Ayaka Momonami Akihisa Maeda Yukari Terashima Wakako Ohyama Takeshi Morita Makoto Hayashi |
author_sort |
Shuichi Hamada |
title |
Evaluation of the novel liver micronucleus assay using formalin-fixed tissues |
title_short |
Evaluation of the novel liver micronucleus assay using formalin-fixed tissues |
title_full |
Evaluation of the novel liver micronucleus assay using formalin-fixed tissues |
title_fullStr |
Evaluation of the novel liver micronucleus assay using formalin-fixed tissues |
title_full_unstemmed |
Evaluation of the novel liver micronucleus assay using formalin-fixed tissues |
title_sort |
evaluation of the novel liver micronucleus assay using formalin-fixed tissues |
publisher |
BMC |
series |
Genes and Environment |
issn |
1880-7062 |
publishDate |
2019-05-01 |
description |
Abstract Background The repeated-dose liver micronucleus (RDLMN) assay is an effective and important in vivo test for detecting genotoxic compounds, particularly for those that require metabolic activation to show genotoxicity. In a collaborative study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/The Japanese Environmental Mutagen Society (JEMS) – Mammalian Mutagenicity Study Group (MMS), micronucleus induction of 22 chemicals with the RDLMN assay employing the collagenase digestion method was examined and reported on. Recently, we have developed a method which enables retrospective evaluation of micronucleus induction in formalin-fixed liver tissues (the formalin-fixed method) obtained in general toxicity studies completed in the past. Using this method, we were able to easily evaluate clastogenic potential of chemicals from the formalin-fixed tissues obtained in the general toxicity studies. In this study, to evaluate the usefulness of the formalin-fixed method, we have conducted a liver micronucleus assay using the formalin-fixed liver samples obtained from the above collaborative study (18 of 22 test chemicals) and carried out a comparison with the results obtained by the collagenase digestion method. Results Comparison of the collagenase digestion and formalin-fixed methods was conducted using the results of the micronucleus assays with a total of 18 test chemicals which included 12 genotoxic hepatocarcinogens (Group A), 4 genotoxic carcinogens but not liver targeted (Group B), and 2 nongenotoxic hepatocarcinogens (Group C). The formalin-fixed method obtained the similar results as the collagenase digestion method in 10 out of the 12 chemicals of Group A, and all chemicals of Group B and Group C. Although the results were statistically contradictive due to different levels of concurrent negative control, the 2 other chemicals of Group A showed comparable responses between the two methods. Conclusion The present study shows that the formalin-fixed method is capable of detecting liver carcinogens with sensitivity equal to or higher than that of the collagenase digestion method. We recommend use of the formalin-fixed method because of its capability of enabling retrospective evaluation of micronucleus induction in the formalin-fixed liver tissues obtained in general toxicity studies completed in the past. |
topic |
Micronucleus assay Liver Formalin-fixed tissue Collagenase Hepatocyte |
url |
http://link.springer.com/article/10.1186/s41021-019-0128-5 |
work_keys_str_mv |
AT shuichihamada evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT miyukishigano evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT satorukawakami evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT mayaueda evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT hajimesui evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT katsuyayamada evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT soichirohagio evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT ayakamomonami evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT akihisamaeda evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT yukariterashima evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT wakakoohyama evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT takeshimorita evaluationofthenovellivermicronucleusassayusingformalinfixedtissues AT makotohayashi evaluationofthenovellivermicronucleusassayusingformalinfixedtissues |
_version_ |
1724942536541208576 |